HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

5th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 18-20 | Hybrid Event

September 18-20, 2025 | London, UK

Gene and Genome Editing

Gene and Genome Editing

Gene and Genome Editing technologies have revolutionized the field of molecular biology, offering powerful tools for precise manipulation of genetic material. Through these techniques, scientists can modify DNA sequences with unprecedented accuracy, enabling targeted alterations in genes and entire genomes. Gene editing involves the direct modification of specific genes within an organism's genome, while genome editing encompasses broader modifications spanning entire genomes. The advent of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) has particularly catalyzed advancements in gene and genome editing, providing researchers with versatile and efficient platforms for genetic engineering. These molecular scissors allow for precise DNA cleavage at targeted locations, facilitating gene knockout, insertion, and modification with remarkable precision. Moreover, CRISPR-based technologies have expanded beyond traditional model organisms, enabling genome editing in a wide range of species, including plants, animals, and even humans. Gene and genome editing hold immense promise for biomedical applications, including the treatment of genetic disorders, cancer therapy, and personalized medicine. Additionally, these technologies have transformative implications for agriculture, enabling the development of crops with enhanced traits such as disease resistance, nutritional value, and yield. However, alongside their tremendous potential, gene and genome editing also raise ethical and safety considerations, particularly regarding off-target effects and unintended consequences.

Committee Members
Speaker at Biotechnology and Bioengineering 2025 - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Biotechnology and Bioengineering 2025 - Steve Busby

Steve Busby

University of Birmingham, United Kingdom
Speaker at Biotechnology and Bioengineering 2025 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
ECBB 2025 Speakers
Speaker at Biotechnology and Bioengineering 2025 - Julia Sidorova

Julia Sidorova

Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Speaker at Biotechnology and Bioengineering 2025 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico
Speaker at Biotechnology and Bioengineering 2025 - Assad Al Ammar

Assad Al Ammar

Specialty Enzymes and Probiotics, United States
Speaker at Biotechnology and Bioengineering 2025 - Tina Moller Tagmose

Tina Moller Tagmose

Novo Nordisk A/S, Denmark
Tags

Submit your abstract Today

Watsapp
a